https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=GENPREX_INCGENPREX INC - Revizia istoricului2026-05-16T20:15:04ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=GENPREX_INC&diff=422169&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei GENPREX INC listata cu simbolurile US.GNPX, US.GNPXc ==Descriere companie== Genprex, Inc. (www.genprex.com) is a clinical-stage gene therapy company focused on developing treatments for cancer and diabetes. The Company's lead cancer drug candidate, REQORSA Immunogene therapy drug (also referred to as GPX-001), is being developed to treat non-small cell lung cancer (NSCLC). The active agent in REQORSA is a TUSC2 gene expressing plasmid that is encaps...2024-09-18T17:59:54Z<p>Pagină nouă: Pagina dedicata companiei GENPREX INC listata cu simbolurile US.GNPX, US.GNPXc ==Descriere companie== Genprex, Inc. (www.genprex.com) is a clinical-stage gene therapy company focused on developing treatments for cancer and diabetes. The Company's lead cancer drug candidate, REQORSA Immunogene therapy drug (also referred to as GPX-001), is being developed to treat non-small cell lung cancer (NSCLC). The active agent in REQORSA is a TUSC2 gene expressing plasmid that is encaps...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei GENPREX INC listata cu simbolurile US.GNPX, US.GNPXc<br />
<br />
==Descriere companie==<br />
Genprex, Inc. (www.genprex.com) is a clinical-stage gene therapy company focused on developing treatments for cancer and diabetes. The Company's lead cancer drug candidate, REQORSA Immunogene therapy drug (also referred to as GPX-001), is being developed to treat non-small cell lung cancer (NSCLC). The active agent in REQORSA is a TUSC2 gene expressing plasmid that is encapsulated in a DOTAP cholesterol nanoparticle. TUSC2 is a tumor suppressor gene which has both tumor killing (via apoptosis) and immunomodulatory effects. The Company utilizes its ONCOPREX Nanoparticle Delivery System to deliver the TUSC2 gene expressing plasmid to cancer cells. Its diabetes gene therapy, also referred to as GPX-002, is designed to work by transforming alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body's immune system.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.GNPX" /><br />
<iframe key="tradeville" path="graficSimbol/US.GNPXc" /><br />
<br />
==Ultimele stiri despre GENPREX INC (US.GNPX)==<br />
<dynamicpagelist><br />
category=US.GNPX<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
==Ultimele stiri despre GENPREX INC (US.GNPXc)==<br />
<dynamicpagelist><br />
category=US.GNPXc<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.GNPX]][[Categorie:US.GNPXc]][[Categorie:Stiri despre companii]]</div>Admin